Table 1.
Time (min)a | Drugs/mAbb | E2Ac | E2Bc | E4Ad | E4Be | E4Ce | E6Af | E6Bf |
---|---|---|---|---|---|---|---|---|
10 | 1.3 | 12 | 88 | 9 | 63 | 28 | N/D | N/D |
20 | 2.1 | 9 | 91 | 7 | 65 | 29 | 7 | 93 |
35 | 2.7 | 9 | 91 | 7 | 63 | 31 | 6 | 94 |
55 | 3.3 | 9 | 91 | 7 | 63 | 30 | 8 | 92 |
80 | 3.6 | 9 | 92 | 7 | 61 | 32 | 6 | 94 |
120 | 3.9 | 11 | 90 | 8 | 61 | 31 | 7 | 93 |
Reduction time. Once reduced, all antibodies were treated with vcMMAE for identical times.
Determined by HIC-HPLC.
Determined from reversed-phase HPLC data using Equation 1.
Determined from capillary electrophoresis data using Equation 3.
Determined from reversed-phase HPLC data using Equations 4 and 5.
Determined from reversed-phase HPLC data using Equation 2. N/D, not determined. At this time point, very little E6 was produced and this material was not sufficient for determining the isomer population.